SURGICAL STRATEGIES IN MULTIDISCIPLINARY MANAGEMENT OF CROHN'S DISEASE

[1]  R. Hurst,et al.  Long-term Results of the Side-to-side Isoperistaltic Strictureplasty in Crohn Disease: 25-year Follow-up and Outcomes. , 2020, Annals of surgery.

[2]  D. Magro,et al.  Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients , 2019, Intestinal research.

[3]  A. Damião,et al.  Postoperative Approach for Crohn's Disease: The Right Therapy to the Right Patient. , 2018, Current drug targets.

[4]  M. Olandoski,et al.  Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case‐matched study , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[5]  F. Shanahan,et al.  Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence , 2018, Journal of Crohn's & colitis.

[6]  C. Buskens,et al.  Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres , 2017, The British journal of surgery.

[7]  C. Buskens,et al.  ECCO-ESCP Consensus on Surgery for Crohn's Disease. , 2017, Journal of Crohn's & colitis.

[8]  M. Olandoski,et al.  Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn’s Disease , 2017, Digestive Diseases and Sciences.

[9]  S. Danese,et al.  Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study , 2016, United European gastroenterology journal.

[10]  R. Prescott,et al.  Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial , 2016, The lancet. Gastroenterology & hepatology.

[11]  M. Regueiro,et al.  Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection. , 2016, Gastroenterology.

[12]  L. Gu,et al.  Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn’s Disease , 2016, World Journal of Surgery.

[13]  Minhu Chen,et al.  Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence. , 2015, Journal of Crohn's & colitis.

[14]  O. Faiz,et al.  Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome. , 2015, Journal of Crohn's & colitis.

[15]  S. Targan,et al.  The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. , 2015, Annals of surgery.

[16]  Yifan Sun,et al.  Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies. , 2015, Journal of Crohn's & colitis.

[17]  Naicheng Liu,et al.  Exclusive Enteral Nutritional Therapy Can Relieve Inflammatory Bowel Stricture in Crohn’s Disease , 2014, Journal of clinical gastroenterology.

[18]  Guanghou Wang,et al.  Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease , 2014, European Journal of Clinical Nutrition.

[19]  A. Ford,et al.  Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. , 2013, Journal of Crohn's & colitis.

[20]  Subrata Ghosh,et al.  Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. , 2013, Gastroenterology.

[21]  Jeroen A. W. Tielbeek,et al.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. , 2013, Journal of Crohn's & colitis.

[22]  Y. Panis,et al.  Surgical management of IBD—from an open to a laparoscopic approach , 2013, Nature Reviews Gastroenterology &Hepatology.

[23]  L. Kotze,et al.  Complication Rates After Bowel Resections for Crohn's Disease: A Brazilian Single‐Center Comparison Between Laparoscopic And Conventional Surgery: P‐110 , 2012 .

[24]  W. Sandborn,et al.  Crohn's disease , 2012, The Lancet.

[25]  Z. Cohen,et al.  Strictureplasty in Selected Crohn’s Disease Patients Results in Acceptable Long-term Outcome , 2012, Diseases of the colon and rectum.

[26]  S. Travis,et al.  Influence of Risk Factors on the Safety of Ileocolic Anastomosis in Crohn’s Disease Surgery , 2012, Diseases of the colon and rectum.

[27]  L. Peyrin-Biroulet,et al.  Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.

[28]  F. Millham,et al.  Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients. , 2012, Archives of surgery.

[29]  S. Jacobson.  Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition , 2012, Scandinavian journal of gastroenterology.

[30]  B. Parry,et al.  Stapled versus handsewn methods for ileocolic anastomoses. , 2011, The Cochrane database of systematic reviews.

[31]  J. Gisbert,et al.  Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[32]  L. Peyrin-Biroulet,et al.  Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease , 2011, Inflammatory bowel diseases.

[33]  L. Bonomo,et al.  CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease. , 2011, The British journal of radiology.

[34]  L. Peyrin-Biroulet,et al.  Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.

[35]  A. Zinsmeister,et al.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.

[36]  F. Pruvot,et al.  Pre‐operative management is associated with low rate of post‐operative morbidity in penetrating Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.

[37]  M. Regueiro,et al.  Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center , 2010, Inflammatory bowel diseases.

[38]  O. Gilja,et al.  Ultrasound and Inflammatory Bowel Disease , 2010, Ultrasound quarterly.

[39]  Takayuki Yamamoto,et al.  Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study , 2009, Inflammatory bowel diseases.

[40]  R. Beart,et al.  Inflammatory Bowel Disease in the United States from 1998 to 2005: Has Infliximab Affected Surgical Rates? , 2009, The American surgeon.

[41]  M. Regueiro,et al.  Infliximab prevents Crohn's disease recurrence after ileal resection. , 2009, Gastroenterology.

[42]  C. Girelli,et al.  Reproducibility of bowel ultrasonography in the evaluation of Crohn's disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[43]  K. Van Steen,et al.  Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort , 2008, Gut.

[44]  V. Fazio,et al.  Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. , 2008, Surgery.

[45]  S. Finlayson,et al.  Trends in Surgery for Crohn's Disease in the Era of Infliximab , 2008, Annals of Surgery.

[46]  E. Vicaut,et al.  Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.

[47]  S. Danese,et al.  Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.

[48]  P. Munkholm,et al.  Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.

[49]  C. Dejong,et al.  ESPEN Guidelines on Enteral Nutrition: Gastroenterology. , 2006, Clinical nutrition.

[50]  A. Darzi,et al.  A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta‐analysis , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[51]  C. Bernstein,et al.  Hospitalization, Surgery, and Readmission Rates of IBD in Canada: A Population-Based Study , 2006, The American Journal of Gastroenterology.

[52]  R. Thisted,et al.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. , 2004, Gastroenterology.

[53]  J. Lewis,et al.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.

[54]  C. Bernstein,et al.  The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study , 2001, Thrombosis and Haemostasis.

[55]  M. Keighley,et al.  Risk factors for intra-abdominal sepsis after surgery in Crohn's disease , 2000, Diseases of the colon and rectum.

[56]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.

[57]  K. Lindor,et al.  Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease. , 1985, Mayo Clinic proceedings.

[58]  S. Steele,et al.  Guideline for the Surgical Management of Crohn ’ s Disease , 2015 .

[59]  Takayuki Yamamoto.  Prevention of Postoperative Recurrence in Crohn’s Disease , 2014, Drugs.

[60]  W. Henderson,et al.  Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. , 1999, Archives of surgery.

[61]  J. Rombeau,et al.  Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. , 1982, American journal of surgery.